Organization
Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands
7 abstracts
Abstract
A NOVEL 3D MODEL OF RHEUMATOID ARTHRITIS SYNOVIAL ANGIOGENESIS TO SCREEN NEW THERAPEUTIC COMPOUNDS Org: Department of Clinical Immunology & Rheumatology, Laboratory for Experimental Immunology, Academic Medical Center/University of Amsterdam, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands,
Abstract
ACTIVATED MEMORY T CELLS PRODUCE LIGANDS THAT CAUSE NF-κB-DEPENDENT INFLAMMATORY ACTIVATION OF THE ENDOTHELIUM: IDENTIFICATION OF NOVEL THERAPEUTIC TARGETSOrg: Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands, Amsterdam UMC, Experimental Immunology, Amsterdam, Netherlands,
Abstract
ANTI-IL-17A TREATMENT BLOCKS INFLAMMATION AND NEW BONE FORMATION IN EXPERIMENTAL SPONDYLOARTHRITIS IN HLA-B27 TRANSGENIC RATS Org: Clinical Immunology and Rheumatology/Experimental Immunology, Academic Medical Center, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands, Novartis Institutes for Biomedical Research, Basel, Switzerland, Rheumatic Diseases Division, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, United States,
Abstract
A RANDOMIZED DOUBLE-BLIND TREATMENT STRATEGY STUDY EVALUATING CONTINUATION OR REDUCED-FREQUENCY DOSING OF CERTOLIZUMAB PEGOL VERSUS WITHDRAWAL TO MAINTAIN LOW DISEASE ACTIVITY IN EARLY RA PATIENTS (C-EARLY PERIOD 2) Org: Weill Cornell College, New York, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands, UCB Pharma, Raleigh, United States, UCB Pharma, Brussels, Belgium,
Abstract
A TAILOR-MADE EXERCISE PROGRAM DESIGNED FOR IMPROVING CARDIORESPIRATORY FITNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INCREASED CARDIOVASCULAR RISKOrg: Amsterdam Rehabilitation Research Center | Reade, Amsterdam, Netherlands, VUMC, Amsterdam, Netherlands, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands, Russel’s Hall Hospital, Dudley, United Kingdom, University of Amsterdam, Faculty of Health, Amsterdam, Netherlands,
Abstract
ASSOCIATION OF BASELINE CYTOTOXIC GENE EXPRESSION WITH USTEKINUMAB RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUSOrg: Janssen Research & Development, LLC, Spring House, PA, United States of America, AMPEL BioSolutions, LLC, Charlottesville, VA, United States of America, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands, University of California, Los Angeles, Los Angeles, CA, United States of America, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States of America,
Abstract
BIOMARKER PROFILING REVEALS NOVEL MECHANISTIC INSIGHTS INTO USTEKINUMAB THERAPEUTIC RESPONSES IN SYSTEMIC LUPUS ERYTHEMATOSUSOrg: Janssen Research and Development, LLC, Spring House, United States of america, AMPEL BioSolutions, LLC, Charlottesville, United States of America, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands, University of California, Los Angeles, Los Angeles, United States of America, Beth Isreal Deaconess Medical Center, Harvard Medical School, Boston, United States of America,